Acorda Therapeutics Inc Beta
Was ist das Beta von Acorda Therapeutics Inc?
Beta von Acorda Therapeutics Inc ist 0.59
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit beta ähnlich Acorda Therapeutics Inc
- Columbia Sportswear Co hat Beta von 0.59
- REF hat Beta von 0.59
- Eon Electric hat Beta von 0.59
- Culp hat Beta von 0.59
- B.P. Marsh & Partners PLC hat Beta von 0.59
- Banco Bradesco S.A hat Beta von 0.59
- Acorda Therapeutics Inc hat Beta von 0.59
- Caribbean Utilities hat Beta von 0.59
- Branded Legacy Inc hat Beta von 0.59
- Icahn Enterprises L P hat Beta von 0.59
- Universal hat Beta von 0.59
- Hi Sun Technology (China) hat Beta von 0.59
- Texmaco Infrastructure & hat Beta von 0.59